Skip to navigation Skip to content



Montana Activists Protect Access to Disease-Modifying Therapies in Montana

October 31, 2014

When the chair of the Society’s Montana Government Relations Committee, Deanna McCann, realized she had a key connection to her state’s Insurance Commissioner, she took action to address the unfair cost-sharing practices for specialty-tier medications by Montana’s insurers. Deanna and fellow activists convinced the Commissioner to investigate the state’s insurance plans’ practices. Now insurers must provide at least one plan option with pre-deductible copays for all drug tiers – meaning that consumers on select plans will pay no more than $250 each month for a disease-modifying drug. In addition, the Commissioner’s office will train Marketplace healthcare navigators to help those needing high-cost medications find these plans. What great steps toward ensuring MS treatments are affordable to all who need them! Read more about Deanna’s success on the Billings Gazette.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization and our Identification Number (EIN) is 13-5661935.